Literature DB >> 6280742

A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.

B D Evans, I E Smith, A J Shorthouse, J L Millar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6280742      PMCID： PMC2010925          DOI： 10.1038/bjc.1982.75

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  Development of a method for assessing the antitumor activity of chemotherapeutic agents using human tumor xenografts.

Authors:  L M Cobb; B C Mitchley
Journal:  Cancer Chemother Rep       Date:  1974 Sep-Oct

2.  Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results.

Authors:  K Mattson; L R Holsti; M Salmo; M Saastamoinen; S Ahlstedt; P Holsti
Journal:  Cancer Treat Rev       Date:  1980-09       Impact factor: 12.111

3.  The therapeutic response of three human tumor lines maintained in immune-suppressed mice.

Authors:  L Kopper; G G Steel
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

4.  The human tumour xenograft--a valid model in experimental chemotherapy?

Authors:  A J Shorthouse; J F Smyth; G G Steel; M Ellison; J Mills; M J Peckham
Journal:  Br J Surg       Date:  1980-10       Impact factor: 6.939

5.  Improved immune-suppression techniques for the exongrafting of human tumours.

Authors:  G G Steel; V D Courtenay; A Y Rostom
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640
  5 in total
  8 in total

Review 1.  Studying lung cancer in the laboratory--2: Chemosensitivity testing.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

Review 2.  Human tumor xenografts as model for drug testing.

Authors:  J Mattern; M Bak; E W Hahn; M Volm
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

3.  Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Authors:  E Buchdunger; J Zimmermann; H Mett; T Meyer; M Müller; U Regenass; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate.

Authors:  Lingying Luo; Xiaoqiang Xu; Beijia Shi; Jinhui Wu; Yiqiao Hu
Journal:  AAPS J       Date:  2007-10-05       Impact factor: 4.009

5.  4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.

Authors:  E Buchdunger; U Trinks; H Mett; U Regenass; M Müller; T Meyer; E McGlynn; L A Pinna; P Traxler; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

6.  Rubus parvifolius L. inhibited the growth of leukemia K562 cells in vitro and in vivo.

Authors:  Xue-jin Zhang; Xiao-feng Xu; Rui-lan Gao; Jian-feng Xu
Journal:  Chin J Integr Med       Date:  2013-11-16       Impact factor: 1.978

7.  High dose cyclophosphamide treatment of human oat cell xenografts in immune deprived mice.

Authors:  B D Evans; I E Smith; J L Millar
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

8.  Synergistic inhibitory effects of an engineered antibody-like molecule ATF-Fc and trastuzumab on tumor growth and invasion in a human breast cancer xenograft mouse model.

Authors:  Hongwei Zhou; Hongwei Wang; Guangyuan Yu; Zhihong Wang; Xi Zheng; Haifeng Duan; Junzhong Sun
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.